RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
208. Culleton BF, Larson MG, Wilson PWF, Evans JC, Parfrey PS,
Parfrey PS, y cols. Cardiovascular disease and mortality in a
community-based cohort with mild renal insufficiency.
Kidney Int 56: 2214-2219, 1999.
209. Garg AX, Clark WF, Haynes RB, House AA: Moderate renal
insufficiency and the risk of cardiovascular mortality: results
from the NHANES I. Kidney Int 61: 1486-1494, 2002.
210. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency
and subsequent death resulting from cardiovascular
disease in the United States. J Am Soc Nephrol 13: 745-753,
2002.
211. Henry RMA, Kostense PJ, Bos G, Dekker JM, Nijpels G,
Heine RJ, y cols. Mild renal insufficiency is associated with
increased cardiovascular mortality: the Hoorn study. Kidney
Int 62: 1402-1407, 2002.
212. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS,
McClellan W: Chronic kidney disease, anemia, and incident
stroke in a middle-aged, community-based population: the
ARIC Study. Kidney Int 64: 610-615, 2003.
213. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB,
Polak JF, y cols. for the Cardiovascular Health Study
Collaborative Research Group: Risk factors for 5-year mortality
in older adults. The Cardiovascular Health Study. JAMA
279: 585-592, 1998.
214. Manjunath G, Tighiouart H, Coresh J, MacLeod B, Salem
DN, Griffith JL, y cols. Level of kidney function as a risk factor
for cardiovascular outcomes in the elderly. Kidney Int 63:
1121-1129, 2003.
215. Fried LP, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS,
Kronmal RA, y cols. Renal insufficiency as a predictor of cardiovascular
outcomes and mortality in elderly individuals. J
Am Coll Cardiol 41: 1364-1372, 2003.
216. Shlipak MG, Fried LP, Stehman-Breen C, Siscovick D,
Newman AB: Chronic renal insufficiency and cardiovascular
events in the elderly: findings from the Cardiovascular
Health Study. Am J Geriatr Cardiol 13: 81-90, 2004.
217. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D,
Langford HG, y cols. Prognostic value of serum creatinine
and effect of treatment of hypertension on renal function:
results from the Hypertension Detection and Follow-up
Program. Hypertension 13 (5 suppl): I80-93, 1989.
218. Flack J, Neaton J, Daniels B, Esunge P: Ethnicity and renal
disease: lessons from the Multiple Risk Factor Intervention
Trial and the Treatment of Mild Hypertension Study. Am J
Kidney Dis 21 (4 Suppl 1): 31-40, 1993.
219. Schillaci G, Reboldi G, Verdecchia P: High-normal serum
creatinine concentration is a predictor of cardiovascular risk
in essential hypertension. Arch Intern Med 161: 886-891,
2001.
220. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt
D, Julius S, y cols. for the HOT study group: Effects of intensive
blood pressure lowering and low-dose aspirin in
patients with hypertension: principal results of the
Hypertension Optimal Treatment (HOT) randomised trial.
Lancet 351: 1755-1762, 1998.
221. Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S,
Kolloch R, y cols. Effects of individual risk factors on the incidence
of cardiovascular events in the treated hypertensive
patients of the Hypertension Optimal Treatment (HOT) study.
J Hypertens 19: 1149-1160, 2001.
222. SHEP Cooperative Research Group: Prevention of stroke by
antihypertensive drug treatment in older persons with isolated
systolic hypertension: final results of the Systolic
Hypertension in the Elderly Program (SHEP). JAMA 265:
3255-3264, 1991.
223. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG,
Birkenhäger WH, y cols. for the Systolic Hypertension in
Europe (Syst-Eur) Trial Investigators: Randomised doubleblind
comparison of placebo and active treatment for older
patients with isolated systolic hypertension. Lancet 350:
757-764, 1997.
224. Wang JG, Staessen JA, Gong L, Liu L, for the Systolic
Hypertension in China (Syst-China) Collaborative Group:
Chinese trial on isolated systolic hypertension in the elderly.
Arch Intern Med 160: 211-220, 2000.
225. Pahor M, Shorr RI, Somes GW, Cushman WC, Ferrucci L,
Bailey JE, y cols. Diuretic-based treatment and cardiovascular
events in patients with mild renal dysfunction enrolled in
the Systolic Hypertension in the Elderly Program. Arch Intern
Med 158: 1340-1345, 1998.
226. Wang JG, Staessen JA, Fagard RH, Birkenhäger WH, Gong L,
Liu L, for the Systolic Hypertension in China (Syst-China)
Trial Collaborative Group: Prognostic significance of serum
creatinine and uric acid in older Chinese patients with isolated
systolic hypertension. Hypertension 37: 1069-1074,
2001.
227. de Leeuw PW, Thijs L, Birkenhäger WH, Voyaki SM,
Efstratopoulos AD, Fagard RH, y cols. for the Systolic
Hypertension in Europe (Sist.-Eur) Trial Investigators:
Prognostic significance of renal function in elderly patients
with isolated systolic hypertension: results from the Syst-Eur
trial. J Am Soc Nephrol 13: 2213-2222, 2002.
228. Segura J, Campo C, Gil P, Roldán C, Vigil L, Rodicio JL, y
cols. Development of chronic kidney disease and cardiovascular
prognosis in essential hypertensive patients. J Am Soc
Nephrol 15: 1616-1622, 2004.
229. Matts JP, Karnegis JN, Campos CT, Fitch LL, Johnson JW,
Buchwald H: Serum creatinine as an independent predictor
of coronary heart disease mortality in normotensive survivors
of myocardial infarction. POSCH Group. J Fam Pract 36:
497-503, 1993.
230. Anderson RJ, O´Brien M, MaWhinney S, VillaNueva CB,
Moritz TE, Sethi GK, y cols. Renal failure predisposes
patients to adverse outcome after coronary artery bypass surgery.
VA Cooperative Study #5. Kidney Int 55: 1057-1062,
1999.
231. Anderson RJ, O´Brien M, MaWhinney S, VillaNueva CB,
Moritz TE, Sethi GK, y cols. Mild renal failure is associated
with adverse outcome after cardiac valve surgery. Am J
Kidney Dis 35: 1127-1134, 2000.
232. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson
LW: The prognostic implications of renal insufficiency in
asymptomatic and symptomatic patients with left ventricular
systolic dysfunction. J Am Coll Cardiol 35: 681-689, 2000.
233. Hillege HL, Girbes AR, de Kam PJ, Boomsma D, de Zeeuw
D, Charlesworth A, y cols. Renal function, neurohormonal
activation, and survival in patients with chronic heart failure.
Circulation 102: 203-210, 2000.
234. McCullough PA, Soman SS, Shah SS, Smith ST, Marks KR,
Yee J, y cols. Risks associated with renal dysfunction in
patients in the coronary care unit. J Am Coll Cardiol 36: 679-
684, 2000.
235. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H,
Bazari H, Palacios IF: Are patients with renal failure good
193